Thought Leadership
-
How would you price one of the world's great watches?
For companies with lots of innovation stuffed in their products, getting the price right is a crucial decision. Stefan Thomke discusses how watchmaker A. Lange & Söhne puts a price on its 173-year-old craftsmanship
-
Ginni Rometty: How purpose helps innovation
The IBM CEO explains why tech needs to do things that matter
-
The evolution of family offices
Family Offices are setup with the primary objective of preserving the family fortunes and for other non-financial purposes like philanthropy, tax advising, or anything else that the family may need
-
The power of an idea meritocracy
The best idea is determined by the quantity and quality of the data, not by positional power
-
Omni channels bring unique challenges to supply chain execution
As damaging as it can be to have empty shelves, the root cause is often that the store inventory count is incorrect
-
Investing with a gender lens
Jackie Vanderbrug, the woman who wrote the book on gender-lens investing describes how important it is to a thriving global economy.
-
Three ways to make your organisation agile
Agile describes the way firms are created around flexible, customer-focused and often self-managed teams, empowering employees to make decisions
-
Should international trade in intellectual property be regulated?
Is intellectual property too valuable an economic asset benefitting the United States to be left unregulated across international borders?
-
Customer service and bias: Starbucks takes stock
Corporations could benefit by actively performing internal audits of customer service to identify opportunities for improvement and also instituting standard scripts and protocols to encourage norms of behaviour
-
The way ahead: Non-intrusive big data
With the impending, all pervasive data analysis techniques, there is now a growing fear whether too many lives will be controlled by too few
-
The side effects of drug price controls
The 2013 Drug Price Control Order capped prices of over 300 drugs in the Indian market. Using an experimental design to assess the consequences of this price control on the anti-diabetic drug Metformin, Professor Chirantan Chatterjee and his co-authors show the unintended consequences of such price regulation